Latest Research And Development News

Gold Hydrogen Limited has secured a $6.45 million R&D tax refund, strengthening its financial position ahead of an ambitious 2025 drilling campaign. The company also announced key leadership changes, including the appointment of a seasoned Chief Geologist.

Rhythm Biosciences has fast-tracked the integration of the geneType™ business, restoring full commercial capabilities ahead of schedule and setting the stage for expanded market reach.

Entyr Limited has received a $3.79 million R&D tax incentive payment for its innovative thermal desorption project targeting rubber waste, reinforcing its position in sustainable tyre recycling technology.

Biotron Limited reported a robust net cash inflow of $1.095 million for the December 2024 quarter, driven largely by government grants, supporting its operational stability despite ongoing R&D expenses.

Alterity Therapeutics has raised over A$2 million through its U.S. ATM facility and expects nearly A$5.7 million in Australian tax rebates, fueling the advancement of its lead neurodegenerative drug candidate ATH434 following promising Phase 2 results.

ResMed Inc. reported robust financial results for the quarter ended December 31, 2024, with a 10% increase in net revenue and a 65% jump in net income, driven by strong demand across its Sleep and Breathing Health and Residential Care Software segments.

WA Kaolin Ltd has marked a pivotal operational milestone in Q4 2024 with the successful commissioning of its classifier project, boosting production and product quality. The company is now poised for growth with increasing sales and a planned equity capital raising.

Rewardle Holdings Limited reported a robust net cash inflow from operating activities of $3.98 million for Q4 2024, offsetting significant investing outflows and ending the quarter with $1.23 million in cash.

Redstone Resources is gearing up for a pivotal drilling campaign at its 100%-owned West Musgrave Copper Project in Western Australia, backed by a $220,000 government grant and strong historical copper grades.

RareX Limited's December 2024 Quarterly Report reveals significant progress in its Khaleesi Niobium and Mt Mansbridge Heavy Rare Earth projects, setting the stage for targeted drilling campaigns in 2025. The company also highlights strategic business development and sustainability initiatives.

Stakk Limited has marked a pivotal quarter with the acquisition of US fintech R-DBX, generating $1.6 million in revenue, and secured a $1 million working capital facility to fuel its Embedded Finance growth strategy.

Skin Elements Limited reports steady progress in commercialising its plant-based SE Formula biotechnology, highlighted by ongoing product trials, a successful R&D rebate, and a $513k non-renounceable entitlement issue.